• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mol Ther . Preventing Occludin Tight-Junction Disruption via Inhibition of microRNA-193b-5p Attenuates Viral Load and Influenza-induced Lung Injury

tetano

Editor, Senior Moderator
Mol Ther


. 2023 Jun 19;S1525-0016(23)00322-2.
doi: 10.1016/j.ymthe.2023.06.011. Online ahead of print. Preventing Occludin Tight-Junction Disruption via Inhibition of microRNA-193b-5p Attenuates Viral Load and Influenza-induced Lung Injury

Chirag M Vaswani[SUP] 1 [/SUP], Amir K Varkouhi[SUP] 2 [/SUP], Sahil Gupta[SUP] 3 [/SUP], Amin M Ektesabi[SUP] 4 [/SUP], James N Tsoporis[SUP] 5 [/SUP], Sadiya Yousef[SUP] 5 [/SUP], Pamela J Plant[SUP] 5 [/SUP], Adriana L da Silva[SUP] 6 [/SUP], Yuchen Cen[SUP] 7 [/SUP], Yi-Chieh Tseng[SUP] 7 [/SUP], Sabrina S Batah[SUP] 8 [/SUP], Alexandre T Fabro[SUP] 8 [/SUP], Suzanne L Advani[SUP] 5 [/SUP], Andrew Advani[SUP] 5 [/SUP], Howard Leong-Poi[SUP] 4 [/SUP], John C Marshall[SUP] 4 [/SUP], Cristiana C Garcia[SUP] 9 [/SUP], Patricia R M Rocco[SUP] 6 [/SUP], Guillermo M Albaiceta[SUP] 10 [/SUP], Steffen Sebastian-Bolz[SUP] 11 [/SUP], Tania H Watts[SUP] 12 [/SUP], Theo J Moraes[SUP] 13 [/SUP], Vera L Capelozzi[SUP] 14 [/SUP], Claudia C Dos Santos[SUP] 15 [/SUP]



Affiliations
Abstract

Virus-induced lung injury is associated with loss of pulmonary epithelial-endothelial tight junction integrity. While the alveolar-capillary membrane may be an indirect target of injury; viruses may interact directly and/or indirectly with miRs to augment their replication potential and evade the host antiviral defense system. Here we expose how the influenza virus (H1N1) capitalizes on host-derived interferon-induced, microRNA (miR)-193b-5p to target occludin and compromise antiviral defenses. Lung biopsies from patients infected with H1N1 revealed increased miR-193b-5p levels, marked reduction in occludin protein, and disruption of the alveolar-capillary barrier. In C57BL/6 mice, the expression of miR-193b-5p increased, and occludin decreased 5-6 days post-infection with influenza (PR8). Inhibition of miR-193b-5p in primary human bronchial, pulmonary microvascular, and nasal epithelial cells enhanced antiviral responses. MiR-193b deficient mice were resistant to PR8. Knockdown of occludin, both in vitro and in vivo, and overexpression of miR-193b-5p reconstituted susceptibility to viral infection. MiR-193b-5p inhibitor mitigated loss of occludin, improved viral clearance, reduced lung edema, and augmented survival in infected mice. Our results elucidate how the innate immune system may be exploited by the influenza virus and how strategies that prevent loss of occludin and preserve tight junction function may limit susceptibility to virus-induced lung injury.


 
Back
Top Bottom